Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Meta Dyrvig Kristensen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|April 2, 2025
Clopidogrel use in chronic coronary syndrome: a fragile lifelong choiceXavier Rossello, Anna Meta Dyrvig Kristensen
Ugeskrift for Laeger|April 17, 2019
Jacob Juel, Anna Meta Dyrvig Kristensen, Manan Pareek
Ugeskrift for Laeger|December 5, 2018
[The cardiovocal syndrome]Anna Meta Dyrvig Kristensen, Mikkel Kaltoft, Mikkel Christian Alanin
Clinical Case Reports|March 23, 2019
Myocardial infarction with simultaneous anterior and inferior ST-segment elevationAnna Meta Dyrvig Kristensen, Sanaz Amin, Christina Byrne, et al.
Clinical Case Reports|June 12, 2019
Conservatively managed saddle pulmonary embolismAnna Meta Dyrvig Kristensen, Victoria Rosberg, Jacob Juel, et al.
European Journal of Preventive Cardiology|March 22, 2023
Temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in European adults with and without diabetesAnna Meta Dyrvig Kristensen, Manan Pareek, Kristian Hay Kragholm, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 2, 2024
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular eventsAnna Meta Dyrvig Kristensen, Manan Pareek, Kristian Hay Kragholm, et al.
Cardiology|May 10, 2022
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and ConsAnna Meta Dyrvig Kristensen, Manan Pareek, Kristian Hay Kragholm, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 4, 2026
Validating National Registry Data for Randomised Trials: Comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trialTherese Lucia Friis Holmager, Anna Meta Dyrvig Kristensen, Morten Wang Fagerland, et al.
European Heart Journal Open|January 4, 2024
Ticagrelor or prasugrel vs. clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention for myocardial infarctionSissel J Godtfredsen, Kristian H Kragholm, Anna Meta Dyrvig Kristensen, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|April 2, 2025
Clopidogrel use in chronic coronary syndrome: a fragile lifelong choiceXavier Rossello, Anna Meta Dyrvig Kristensen
Ugeskrift for Laeger|April 17, 2019
Jacob Juel, Anna Meta Dyrvig Kristensen, Manan Pareek
Ugeskrift for Laeger|December 5, 2018
[The cardiovocal syndrome]Anna Meta Dyrvig Kristensen, Mikkel Kaltoft, Mikkel Christian Alanin
Clinical Case Reports|March 23, 2019
Myocardial infarction with simultaneous anterior and inferior ST-segment elevationAnna Meta Dyrvig Kristensen, Sanaz Amin, Christina Byrne, et al.
Clinical Case Reports|June 12, 2019
Conservatively managed saddle pulmonary embolismAnna Meta Dyrvig Kristensen, Victoria Rosberg, Jacob Juel, et al.
European Journal of Preventive Cardiology|March 22, 2023
Temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in European adults with and without diabetesAnna Meta Dyrvig Kristensen, Manan Pareek, Kristian Hay Kragholm, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|February 2, 2024
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular eventsAnna Meta Dyrvig Kristensen, Manan Pareek, Kristian Hay Kragholm, et al.
Cardiology|May 10, 2022
Unstable Angina as a Component of Primary Composite Endpoints in Clinical Cardiovascular Trials: Pros and ConsAnna Meta Dyrvig Kristensen, Manan Pareek, Kristian Hay Kragholm, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|April 4, 2026
Validating National Registry Data for Randomised Trials: Comparison of registry-derived cardiovascular events with and without adjudication in the BETAMI-DANBLOCK trialTherese Lucia Friis Holmager, Anna Meta Dyrvig Kristensen, Morten Wang Fagerland, et al.
European Heart Journal Open|January 4, 2024
Ticagrelor or prasugrel vs. clopidogrel in patients with atrial fibrillation undergoing percutaneous coronary intervention for myocardial infarctionSissel J Godtfredsen, Kristian H Kragholm, Anna Meta Dyrvig Kristensen, et al.
Pageof 3